To the editor, fibrosis (CF) (1-4) and is increasingly being used as a surrogate efficacy endpoint in CF clinical 17 trials (5,6). LCI is reliable and more sensitive than FEV1 in detecting lung disease in infants, 18 children and adults with CF (7-9), tracks early disease progression and symptoms (3) and 19 predicts the onset of pulmonary exacerbations (10). LCI has been shown to be elevated in 20 infants and younger children with respiratory infection and correlates with airway 21 inflammation, measured using a range of biomarkers in bronchoalveolar lavage (11-13).
22
However, there is little data on how LCI relates to markers of infection and inflammation, in 23 children > 6 years and adults.
24
Whilst it is widely recognised that pulmonary infection results in an excessive 25 inflammatory response in the CF airways, the potential role of inflammation as an independent 26 contributor to CF pathophysiology is also established. 
Results

57
One hundred and ten CF subjects were recruited, with data collected at a stable visit. The mean 
60
A sputum or throat swab sample was successfully collected from 106/110 subjects 61 (n=68 sputum, n=38 throat swabs). Four subjects were unable to provide a sample.
62
Pseudomonas aeruginosa was detected in 40/106 (37%) subjects (82% sputum, 18% throat 
Discussion
92
In this study, we demonstrated that LCI was significantly elevated in P. aeruginosa positive 93 subjects compared with P. aeruginosa negative subjects, indicating that it may be a sensitive 94 marker of P. aeruginosa infection in CF children and adults. LCI was significantly elevated in 95 subjects with non P. aeruginosa infection compared to those subjects with no significant 96 growth, whereas FEV1% predicted showed no difference. Furthermore, this is the first study to 97 show that increased WCC, as a potential marker of infection, and increased CRP as a marker The results from this study including older children and adults are in agreement with 101 studies in infants and younger children reporting a significant relationship between elevated 102 LCI and the presence of lower respiratory tract infection (12, 13) The results of this study demonstrate that LCI is a sensitive marker of infection and 135 inflammation in older children and adults when clinically stable, providing additional 136 information to FEV1% predicted, even in subjects with more advanced disease. These results
137
further validate LCI as a useful outcome measure in this age range.
138
In previous studies, it has been shown that children with normal spirometry are the 
